Mediroute: An open-source AI platform exposing global drug price disparities

MediRoute is an open-source HealthTech, RegTech and AI Agent platform that compares drug prices across five markets (US, Canada, India, Singapore, UK), checks import legality with cited compliance rules, and offers an AI Medicine Agent, a Drug Shortage Radar and supplier Trust Scores. It cites the example of Imatinib costing $9,800/month in the US versus $208/month from India, and states it is a medicine intelligence platform rather than a pharmacy or marketplace. The MVP covers 8 flagship drugs, 20 bilateral compliance lanes and three languages, with a roadmap toward 100 countries and 100,000 drugs.